Vetter Plans Expansion in Illinois
PTSM: Pharmaceutical Technology Sourcing and Management
The company plans to purchase and develop an 18-acre site in Des Plaines, Illinois.
During a meeting held on July 12, 2016, Vetter Pharma shared its potential plan to purchase and develop an 18-acre site located in Des Plaines, Illinois. According to the company, the intention of this expansion is to offer its global customer base a US manufacturing opportunity.
For this project, Vetter plans to invest approximately $320 million in construction and site improvements in a more than 10-year period. Once it has reached its final expansion stage, the 18-acre site would include 1,138,237 square feet of facility space. If approved, the facility would be the company’s second US manufacturing site. The Des Plaines facility would lead to the possible creation of between 400–500 jobs by the final expansion stage, Vetter noted.
Source: Vetter Pharma
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
